Tau and α-synuclein distribution in subtypes of dementia with Lewy bodies

Takeaway

  • Clinical phenotypes of dementia with Lewy bodies (DLB) are associated with the distribution of α-synuclein and tau pathology.

Why this matters

  • Diagnosis of DLB based on neuropathologic features such as α-synuclein is widely established; however, any clinical signatures or patterns associated with DLB subgroups are yet to be established.

  • Identification of clinical phenotypes associated with specific neuropathological patterns in DLB could have potential implications for management of this condition.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.